{"id":53229,"name":"HEALTH EQUITY COALITION FOR CHRONIC DISEASE","slug":"health-equity-coalition-for-chronic-disease","state":"DC","country":"United States of America","description":"Coalition advancing health equity of care and treatment for obesity & chronic diseases.","totalSpending":670000,"filings":15,"yearlySpending":[{"year":2022,"income":40000},{"year":2023,"income":200000},{"year":2024,"income":270000},{"year":2025,"income":160000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["NVG, LLC"],"lobbyists":["JULIO LAINEZ","EDEN SHIFERAW","IRENE BUENO"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to coverage for anti-obesity agents under Medicare Part D.","Issues related to coverage for anti-obesity agents under Medicare Part D. H.R.7585 - Health Equity and Accountability Act of 2022. H.R.1577/S.596 - Treat and Reduce Obesity Act of 2021.","Issues related to coverage for anti-obesity agents under Medicare Part D. H.R.7585 - Health Equity and Accountability Act of 2022. H.R.1577/S.596 - Treat and Reduce Obesity Act of 2021.","Issues related to coverage for anti-obesity agents under Medicare Part D. Health Equity and Accountability Act (Legislation not yet introduced). Treat and Reduce Obesity Act (Legislation not yet intro","Issues related to coverage for anti-obesity agents under Medicare Part D."]}